Natural Health Trends Corp.
NHTC
$5.19
-$0.03-0.58%
Weiss Ratings | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | B- | |||
Rating Factors | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Excellent | |||
Growth Index | Fair | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.58 | |||
Price History | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 7.45% | |||
30-Day Total Return | 7.75% | |||
60-Day Total Return | 6.83% | |||
90-Day Total Return | -13.31% | |||
Year to Date Total Return | 14.10% | |||
1-Year Total Return | -18.77% | |||
2-Year Total Return | -9.74% | |||
3-Year Total Return | -38.43% | |||
5-Year Total Return | 86.45% | |||
52-Week High % Change | -29.46% | |||
52-Week Low % Change | 29.85% | |||
Price | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $7.40 | |||
52-Week Low Price | $4.02 | |||
52-Week Low Price (Date) | Dec 16, 2024 | |||
52-Week High Price (Date) | May 10, 2024 | |||
Valuation | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 59.95M | |||
Enterprise Value | 18.65M | |||
Price/Earnings (TTM) | 104.82 | |||
Earnings Per Share (TTM) | 0.05 | |||
Earnings Per Share Growth | 10.67% | |||
Price/Earnings To Growth | 9.83 | |||
Price/Sales (TTM) | 1.40 | |||
Price/Book (Q) | 1.82 | |||
Enterprise Value/Revenue (TTM) | 0.43 | |||
Price | $5.19 | |||
Enterprise Value/EBITDA (TTM) | -15.97 | |||
Enterprise Value/EBIT | -14.36 | |||
Market Cap Category | Micro Cap | |||
Dividends and Shares | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 11.49M | |||
Dividend Yield | 15.33% | |||
Div. Per Share (Most Recent) | $0.20 | |||
Dividend Per Share (TTM) | $0.80 | |||
Payout Ratio (TTM) | 1,610.66% | |||
Dividend Per Share (Most Recent) | $0.20 | |||
Company Info | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 310 541 0888 | |||
Address | 609 Deep Valley Drive Rolling Hills Estates, CA 90274 | |||
Website | www.naturalhealthtrendscorp.com | |||
Country | United States | |||
Year Founded | 1988 | |||
Profitability | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -3.02% | |||
Profit Margin | 1.33% | |||
Management Effectiveness | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -1.30% | |||
Return on Equity | 1.54% | |||
Income Statement | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 42.96M | |||
Total Revenue (TTM) | 42.96M | |||
Revenue Per Share | $3.74 | |||
Gross Profit (TTM) | 31.79M | |||
EBITDA (TTM) | -1.17M | |||
EBIT (TTM) | -1.30M | |||
Net Income (TTM) | 572.00K | |||
Net Income Avl. to Common (TTM) | 572.00K | |||
Total Revenue Growth (Q YOY) | -0.83% | |||
Earnings Growth (Q YOY) | -50.84% | |||
EPS Diluted (TTM) | 0.05 | |||
EPS Diluted Growth (Q YOY) | -49.00% | |||
Balance Sheet | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 43.94M | |||
Cash Per Share (Q) | $3.83 | |||
Total Current Assets (Q) | 50.98M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 32.87M | |||
Current Ratio (Q) | 2.451 | |||
Book Value Per Share (Q) | $2.86 | |||
Total Assets (Q) | 55.36M | |||
Total Current Liabilities (Q) | 20.80M | |||
Total Debt (Q) | 2.64M | |||
Total Liabilities (Q) | 22.49M | |||
Total Common Equity (Q) | 32.87M | |||
Cash Flow | NHTC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -30.08M | |||
Cash from Financing (TTM) | -9.21M | |||
Net Change in Cash (TTM) | -42.65M | |||
Levered Free Cash Flow (TTM) | 1.54M | |||
Cash from Operations (TTM) | -3.37M | |||